Literature DB >> 25547568

Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age.

Ingvild Odsbu1, Svetlana Skurtveit, Randi Selmer, Christine Roth, Sonia Hernandez-Diaz, Marte Handal.   

Abstract

PURPOSE: The aim of the study was to examine if there was an association between use of anxiolytics and hypnotics in pregnancy and language competence in the offspring at age 3 years.
METHODS: The Norwegian Mother and Child Cohort Study (MoBa) is a prospective pregnancy cohort where the mothers were asked to report on their medication use at pregnancy week 17-18, 30, and at 6 months postpartum. A woman was defined as a user of anxiolytics and hypnotics during pregnancy if she had reported use of benzodiazepines or benzodiazepine-related drugs during pregnancy. Children's language competence was measured at age three by maternal report on a validated language grammar scale. We used ordinal logistic regression with estimated standard errors allowing for clustering of multiple pregnancies.
RESULTS: Forty-five thousand and two hundred sixty-six women with 51,748 pregnancies were included in the study. The women reported use of anxiolytics and/or hypnotics in 395 pregnancies (0.8 %). The odds ratios of being in a group with lower language competence were 1.2 (0.9-1.5) and 1.7 (1.0-2.8) for short-term and long-term anxiolytics and hypnotics use, respectively. When adjusting for SSRI use during pregnancy, the odds ratios were 1.1 (0.83-1.41) and 1.4 (0.84-2.33), respectively. Children whose mothers took no anxiolytics and hypnotics during or before pregnancy were reference group.
CONCLUSION: The results refute any strong association between prenatal use of anxiolytics and hypnotics and lower language competence in the offspring at age 3 years.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547568     DOI: 10.1007/s00228-014-1797-4

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  27 in total

1.  Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa).

Authors:  Per Magnus; Lorentz M Irgens; Kjell Haug; Wenche Nystad; Rolv Skjaerven; Camilla Stoltenberg
Journal:  Int J Epidemiol       Date:  2006-08-22       Impact factor: 7.196

2.  Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004-2006.

Authors:  Anders Engeland; Jørgen G Bramness; Anne Kjersti Daltveit; Marit Rønning; Svetlana Skurtveit; Kari Furu
Journal:  Br J Clin Pharmacol       Date:  2008-02-20       Impact factor: 4.335

3.  Anxiety in early pregnancy: prevalence and contributing factors.

Authors:  C Rubertsson; J Hellström; M Cross; G Sydsjö
Journal:  Arch Womens Ment Health       Date:  2014-01-18       Impact factor: 3.633

4.  "Floppy infant syndrome" and maternal diazepam.

Authors:  C Gillberg
Journal:  Lancet       Date:  1977-07-30       Impact factor: 79.321

5.  Effects of pregnancy on mothers' sleep.

Authors:  C Hedman; T Pohjasvaara; U Tolonen; A S Suhonen-Malm; V V Myllylä
Journal:  Sleep Med       Date:  2002-01       Impact factor: 3.492

6.  Point prevalence of psychiatric disorders during the second trimester of pregnancy: a population-based study.

Authors:  Liselott Andersson; Inger Sundström-Poromaa; Marie Bixo; Marianne Wulff; Karin Bondestam; Monica åStröm
Journal:  Am J Obstet Gynecol       Date:  2003-07       Impact factor: 8.661

7.  Neurodevelopment in late infancy after prenatal exposure to benzodiazepines--a prospective study.

Authors:  L Laegreid; G Hagberg; A Lundberg
Journal:  Neuropediatrics       Date:  1992-04       Impact factor: 1.947

8.  Withdrawal symptoms in neonates from intrauterine exposure to diazepam.

Authors:  J L Rementería; K Bhatt
Journal:  J Pediatr       Date:  1977-01       Impact factor: 4.406

9.  Prenatal exposure to antidepressants and language competence at age three: results from a large population-based pregnancy cohort in Norway.

Authors:  S Skurtveit; R Selmer; C Roth; S Hernandez-Diaz; M Handal
Journal:  BJOG       Date:  2014-04-14       Impact factor: 6.531

10.  Outcomes of early language delay: I. Predicting persistent and transient language difficulties at 3 and 4 years.

Authors:  Philip S Dale; Thomas S Price; Dorothy V M Bishop; Robert Plomin
Journal:  J Speech Lang Hear Res       Date:  2003-06       Impact factor: 2.297

View more
  5 in total

Review 1.  Cognitive outcomes of prenatal antiepileptic drug exposure.

Authors:  Katherine Inoyama; Kimford J Meador
Journal:  Epilepsy Res       Date:  2015-05-02       Impact factor: 3.045

2.  Association Between Prenatal Valproate Exposure and Performance on Standardized Language and Mathematics Tests in School-aged Children.

Authors:  Lars Skou Elkjær; Bodil Hammer Bech; Yuelian Sun; Thomas Munk Laursen; Jakob Christensen
Journal:  JAMA Neurol       Date:  2018-06-01       Impact factor: 18.302

3.  Narrowing the Genetic Causes of Language Dysfunction in the 1q21.1 Microduplication Syndrome.

Authors:  Antonio Benítez-Burraco; Montserrat Barcos-Martínez; Isabel Espejo-Portero; Maite Fernández-Urquiza; Raúl Torres-Ruiz; Sandra Rodríguez-Perales; Ma Salud Jiménez-Romero
Journal:  Front Pediatr       Date:  2018-06-05       Impact factor: 3.418

4.  Prenatal Drug Exposure in Children With a History of Neuropsychiatric Care: A Nested Case-Control Study.

Authors:  Justine Benevent; Caroline Hurault-Delarue; Mélanie Araujo; Alexis Revet; Agnès Sommet; Isabelle Lacroix; Christine Damase-Michel
Journal:  Front Psychiatry       Date:  2022-03-22       Impact factor: 4.157

Review 5.  Use of Prescribed Psychotropics during Pregnancy: A Systematic Review of Pregnancy, Neonatal, and Childhood Outcomes.

Authors:  Catherine E Creeley; Lisa K Denton
Journal:  Brain Sci       Date:  2019-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.